Literature DB >> 30326273

Why surveillance of antimicrobial resistance needs to be automated and comprehensive.

Thomas F O'Brien1, Adam Clark1, Rob Peters1, John Stelling2.   

Abstract

OBJECTIVES: Surveillance of antimicrobial resistance (AMR) can now be automated to analyse the reports of microbiology laboratories continually without operator assistance. It can also be made comprehensive to monitor all the reports of all the world's microbiology laboratories. METHODS AND
RESULTS: As illustrated through examples provided in this work, each clinical report can be scanned automatically by algorithms to suspect emerging problems and to prompt sampling to confirm such problems, now increasingly by nucleotide sequencing. An emerging problem may be an excess (clustering) of similar microbes owing to their spread among patients who are interrelated in some way, as by shared locations, caregivers or food products. Or it might be a microbe new to an area or to a laboratory but already seen nearby, such as Elizabethkingia anophelis or mcr-1-positive Escherichia coli. Automated early alerting of responders enables them to contain spread sooner and to avert infections downstream. 'Big Data' informatics now also enables surveillance of AMR to be made comprehensive, to monitor all reports of all the world's microbiology laboratories. Such orders of magnitude increase in analysed data would accordingly increase its granularity and thus detect many more global problems sooner. It would also reduce surveillance-blind areas where problems may now emerge and spread undetected.
CONCLUSIONS: The world's microbiology laboratories need to integrate and analyse all of their reports for surveillance to make their own patients safer from existing and approaching problems otherwise hard to notice. Making automated surveillance an easy-to-adopt laboratory standard of care can make it comprehensive.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Antimicrobial resistance; Automation; Outbreak detection; SaTScan; Surveillance; WHONET

Mesh:

Substances:

Year:  2018        PMID: 30326273     DOI: 10.1016/j.jgar.2018.10.011

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  8 in total

Review 1.  Consolidation of Clinical Microbiology Laboratories and Introduction of Transformative Technologies.

Authors:  Zisis Kozlakidis; Alex van Belkum; Olivier Vandenberg; Géraldine Durand; Marie Hallin; Andreas Diefenbach; Vanya Gant; Patrick Murray
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

2.  Three Years of Evaluation to Determine Reduction of Antibiotic Resistance in Gram-Negative Bacteria by the Saudi National Action Plan.

Authors:  Meshari Alabdullatif; Jihad Alrehaili
Journal:  Infect Drug Resist       Date:  2020-10-19       Impact factor: 4.003

3.  Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children's Hospital, Tehran, Iran: 2013-2018.

Authors:  Taher Azimi; Saied Maham; Fatemeh Fallah; Leila Azimi; Zari Gholinejad
Journal:  Infect Drug Resist       Date:  2019-07-17       Impact factor: 4.003

Review 4.  Leapfrogging laboratories: the promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings.

Authors:  Iruka N Okeke; Nicholas Feasey; Julian Parkhill; Paul Turner; Direk Limmathurotsakul; Pantelis Georgiou; Alison Holmes; Sharon J Peacock
Journal:  BMJ Glob Health       Date:  2020-12

5.  In Vitro Activity Of Ceftaroline And Comparators Against Staphylococcus aureus Isolates: Results From 6 Years Of The ATLAS Program (2012 To 2017).

Authors:  Zhijie Zhang; Meng Chen; Ying Yu; Beini Liu; Yong Liu
Journal:  Infect Drug Resist       Date:  2019-10-24       Impact factor: 4.003

6.  Automating the Generation of Antimicrobial Resistance Surveillance Reports: Proof-of-Concept Study Involving Seven Hospitals in Seven Countries.

Authors:  Cherry Lim; Thyl Miliya; Vilada Chansamouth; Myint Thazin Aung; Abhilasha Karkey; Prapit Teparrukkul; Batra Rahul; Nguyen Phu Huong Lan; John Stelling; Paul Turner; Elizabeth Ashley; H Rogier van Doorn; Htet Naing Lin; Clare Ling; Soawapak Hinjoy; Sopon Iamsirithaworn; Susanna Dunachie; Tri Wangrangsimakul; Viriya Hantrakun; William Schilling; Lam Minh Yen; Le Van Tan; Htay Htay Hlaing; Mayfong Mayxay; Manivanh Vongsouvath; Buddha Basnyat; Jonathan Edgeworth; Sharon J Peacock; Guy Thwaites; Nicholas Pj Day; Ben S Cooper; Direk Limmathurotsakul
Journal:  J Med Internet Res       Date:  2020-10-02       Impact factor: 5.428

7.  Global trends of antimicrobial susceptibility to ceftaroline and ceftazidime-avibactam: a surveillance study from the ATLAS program (2012-2016).

Authors:  Hui Zhang; Yingchun Xu; Peiyao Jia; Ying Zhu; Ge Zhang; Jingjia Zhang; Simeng Duan; Wei Kang; Tong Wang; Ran Jing; Jingwei Cheng; Yali Liu; Qiwen Yang
Journal:  Antimicrob Resist Infect Control       Date:  2020-10-27       Impact factor: 4.887

8.  Automated digital reporting of clinical laboratory information to national public health surveillance systems, results of a EU/EEA survey, 2018.

Authors:  Katrin Claire Leitmeyer; Laura Espinosa; Eeva Kaarina Broberg; Marc Jean Struelens
Journal:  Euro Surveill       Date:  2020-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.